| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Oxford Quantum Circuits (OQC) We build quantum computers and enable life-changing discoveries. Quantum computing is poised to reshape our world by addressing the complex challenges we face today. We deliver enterprise-ready quantum solutions that will empower humanity with quantum capabilities, paving the way for a brighter future. quantum, Computing, hardware, physics, electronics, cryogenics, quantum software, and quantum hardware Type: | 12 | 128 |
 |  Eden Scott Eden Scott - The People Business (Edinburgh, Glasgow and Aberdeen) Eden Scott is a Scottish recruitment business with more than 65 consultants in its offices located in Edinburgh, Glasgow, Aberdeen and Belfast. With an international outlook, our services cover both local and international territories - drawing on a wealth of experience in recruitment across the globe - covering Europe, the Middle East and Africa, Asia Pacific and the Americas. We provide bespoke recruitment solutions for often complex campaigns; covering both professional and technical staffing markets, across permanent, temporary and contract positions. As an independent consultancy, we partner with clients to … | 11 | 58 |
 | Nuffield Department of Medicine Saving lives and improving the quality of life by advancing the diagnosis, prevention and treatment of disease. The Nuffield Department of Medicine (NDM) at the University of Oxford has a global reach and significant breadth in terms of capabilities and capacity. Our research and innovations have had many positive impacts on human health, including in infectious diseases, cancer, immunology, gastroenterology, respiratory and renal medicine, vaccinology, pathology and general medicine. The Nuffield Department of Medicine's vision is Universal Health. Our mission is to save lives and improve the quality of life by advancing the diagnosis, prevention and treatment of disease. We … Type: | 11 | 106 |
 | Milton Keynes University Hospital NHS Foundation Trust Milton Keynes University Hospital NHS Foundation Trust (MKUH) is a medium-sized general hospital that provides acute and specialist services to people living in Milton Keynes, and areas of Buckinghamshire, Northamptonshire, Bedfordshire and Oxfordshire. MKUH has 550 beds and employs over 4,000 staff who care for over half a million patients every year. Since 2017, the Trust has worked in partnership with the University of Buckingham to operate its own state-of-the-art medical school. Milton Keynes is recognised as one of the fastest-growing cities in the UK and, as a result, demand on MKUH is continually increasing. In recent years, MKUH has … Type: | 9 | 1,515 |
 | Hostplus We’re an Industry SuperFund that provides our members the financial future they deserve. That's a plus. We’re an Industry SuperFund that works tirelessly to provide our members the financial future they deserve. A future full of good stuff. A future full of positivity. That’s a plus. Superannuation Type: | 6 | 390 |
 | National Institute of Standards and Technology (NIST) Measure. Innovate. Lead. We are the National Institute of Standards and Technology (NIST), a non-regulatory federal agency within the U.S. Department of Commerce. For more than a century, NIST has helped to keep U.S. technology at the leading edge. Our measurements support the smallest of technologies to the largest and most complex of human-made creations. NIST's mission is to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards, and technology in ways that enhance economic security and improve our quality of life. See what innovative work we’re doing to support it: https://www.nist.gov/ Standards, Metrology, Advanced Communications, Artificial Intelligence, … Type: | 76 | 4,949 |
 | Evotec #researchneverstops Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and … Type: | 30 | 4,926 |
 | BioIndustry Association (BIA) The award-winning trade association for the innovative life sciences and biotech companies in the UK The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation. BIA is a trade association with 490+ member companies including: - Start-ups, biotechnology and innovative life science companies - Pharmaceutical and technological companies - Universities, research centres, tech transfer offices, incubators and accelerators - A wide range of life science service providers: investors, lawyers, IP consultants, IR agencies BIA is the key thought leader … Type: | 53 | 72 |
 | Alnylam Pharmaceuticals Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep pipeline and global reach. SILENCE DISEASE. AMPLIFY LIFE.TM Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi … Type: | 34 | 2,459 |
 | Northstar Ventures UK Northstar Ventures is a venture capital firm based in the North East of England. We invest in innovative, high growth businesses and social enterprises across the region. We are dedicated to providing entrepreneurs with the support they need to fulfill their ambitions and to achieve social impact through our investments. Follow us on Twitter: @NorthstarVent Northstar Ventures Limited is authorised and regulated by the Financial Conduct Authority. Northstar Ventures Limited is a limited company registered in England and Wales with company number 0510 4995. Registered office: 5th Floor, Maybrook House, 27-35 Grainger Street, Newcastle upon Tyne, NE1 5JE. Venture Capital … Type: | 35 | 23 |
 | British Private Equity & Venture Capital Association (BVCA) The representative body for the UK's private equity and venture capital industries The British Private Equity & Venture Capital Association (BVCA) is the voice of private capital in the UK. We have been advocating for the UK’s private equity and venture capital industry for 40 years, helping it to uphold its vision and achieve its goals. We actively represent this diverse community of long-term investors, enabling them to speak with one clear and consistent voice to society, including the Government, media and MPs. We connect institutional investors, fund managers, companies, advisers and service providers together, with our membership currently comprising … Type: | 39 | 136 |
 | Arrival Zero-emission solutions for cities. Human-centred, intelligent design - to revitalise public transportation. Zero-emission solutions for cities. Human-centred, intelligent design - to revitalise public transportation. electric vehicles, mobility, technology, AI, logistics, engineering, UX, UI, design, software, robotics, IoT, manufacturing, EVs, commercial vehicles, and sustainability Type: | 35 | 376 |
 | Huma Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research. Huma’s technology has powered over 3,000 hospitals and clinics, with 500+ unique deployments across 70+ countries. The software has been used to engage and screen over 35 million individuals, with 1.8 million active users across its various products. The company is renowned for its role in major national healthcare projects worldwide, from the US and the UK to … Type: | 36 | 242 |
 | The Oxford Science Park The Oxford Science Park is one of the most influential science, technology and business environments in the UK for more than 2,500 people in over 70 companies, ranging from start-ups to SMEs and multi-national organisations. It was created in 1991 and is owned and managed by Magdalen College Oxford, one of Oxford’s oldest and most famous colleges with a tradition of academic excellence and entrepreneurship. The Park continues to uphold the College’s heritage. People who work here enjoy 75 acres of beautifully landscaped grounds and an atmosphere of discovery, innovation and entrepreneurship. Offices, Laboratories, and Conference and Meeting rooms for … Type: | 36 | 14 |
 | Oxfordshire Local Enterprise Partnership (OxLEP) OxLEP is a business-led organisation helping to strengthen the Oxfordshire economy, supporting the creation of jobs. The Oxfordshire Local Enterprise Partnership (OxLEP) is responsible for championing and developing the Oxfordshire economy. Our vision for Oxfordshire is for it to be: 'a vibrant, sustainable, inclusive, world-leading economy - driven by innovation, enterprise and research excellence.' We champion the economic growth for Oxfordshire through four priorities; people, place, enterprise and connectivity. Economic development, Business growth, Apprenticeships, B2B, Start ups, Inward investment, Strategy, Innovation, Transformative Technology, Internationalisation, Funding, Grants, and Brexit Advice Type: | 14 | 44 |
 | Theolytics Transforming patients’ lives | Through world leading science | With a great team Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development. Biotech, Oncology, and Virology | 3 | 27 |
 | Quantum Dice Securing a connected future. Quantum Dice is an award-winning, fast growing quantum technology and photonics developer backed by world leading innovation from the University of Oxford. Providing random number generation (QRNGs) which generate unbiased, true random numbers. RNGs are essential components of modern communication technologies which generate cryptographically secure keys for enterprise and user needs. Quantum Random Number Generator, Cybersecurity, Quantum, Photonics, and Hardware Type: | 20 | 20 |
 | Octopus Ventures For the people and ideas that will change the world. Octopus Ventures, part of Octopus Group, is one of the largest and most active venture capital investors in the UK and Europe. We’re on a mission to invest in the people, ideas and industries that will change the world. We back entrepreneurs ─ from the first cheque their business receives, right through to IPO. We manage £1.8bn and are investing in more than 200 businesses, focusing on the companies solving three of the world’s biggest problems: those building a sustainable planet, empowering people, and revitalising healthcare. We know what it … Type: | 88 | 112 |
 |  Vito Ventures German Engineering Capital GERMAN ENGINEERING CAPITAL. We invest in break-through technology and business innovations. Globally. WHAT WE DO We back ambitious founders and startups applying cutting-edge technology to challenge and re-invent the way of doing business. We believe that superb engineering and radical entrepreneurial thinking is needed to tackle major challenges of the upcoming decades. With our investments we empower startups, which will make a difference both within their industry and beyond. WHAT WE SEEK We look out for teams who question the status quo and think big. Our founders should be rigorous executors and creative visionaries who are restless … Type: | 7 | 2 |
 | Inovia Capital Inovia is a VC firm that partners with founders to build impactful and enduring global companies #CompanyBuilders Inovia Capital is a venture capital firm that partners with founders to build impactful and enduring global companies. The team leverages an operator-led mindset to provide founders with multi-stage support, mentorship, and access to a worldwide network. Inovia manages over US$2.5B with operations in Montreal, Toronto, Waterloo, Calgary, and London. For more information, visit inovia.vc. Entrepreneurial Capital, Seed and Early Stage Venture Capital, and Growth Capital Type: | 55 | 105 |
 | EdTechX EdTechX, powered by IBIS Capital, provides insights and analysis of global markets through our X Report and event series We're thrilled to announce the return of the EdTechX Summit in 2025, where the future of education, training and work takes centre stage! Set within the vibrant London EdTech Week programme, this exclusive headline event is limited to 300 senior industry leaders, ensuring an intimate and dynamic experience between founders, CEOs, policymakers, senior executives, and investors. From 16 - 20 June 2025, London EdTech Week will engage the entire EdTech ecosystem across London, through our collaborative and community-led programme. Working with … Type: | 37 | 4 |
 | Swisscom Ventures Empowering tomorrow's global tech winners Swisscom Ventures is the venture capital arm of Swisscom AG, the leading telecommunications and IT provider in Switzerland. Since our inception in 2007, we have invested in over 70 IT, digital media and telecommunication companies from our offices in Switzerland (Zurich and Lausanne) and the USA (Silicon Valley). As a strategic investor, we offer entrepreneurs access to our technical infrastructure and market channels in addition to financial support. We focus on sectors of domain expertise such as Telco & IT Cloud, DeepTech, Cybersecurity and Fintech as well as Big Data & AI related new business … Type: | 13 | 22 |
 | Serelay We enable any mobile device user to capture verifiable photos and videos Serelay is establishing the industry standard for trusted digital media capture - enabling mobile devices to capture photos and videos which can be queried for authenticity of content and metadata. Type: | 9 | 1 |
 | The Growth Company The Growth Company drives forward economic, personal and professional development within communities by boosting employment, skills, investment and enterprise for the benefit of all. As a not-for-profit, we’re driven by success - not shareholders - which means we reinvest any money we make and are dedicated to making a positive difference and leaving a legacy of growth. We’re at the heart of placemaking in the UK and seek to drive inward investment and encourage international companies to set up shop on our shores. The Growth Company also plays a key role in developing fruitful business relationships between British cities and … Type: | 13 | 959 |
 | University of Oxford, Department of Engineering Science 100 years of educating great engineers and research at the cutting edge at the University of Oxford. www.eng.ox.ac.uk. The Department of Engineering Science at the University of Oxford offers accredited courses in all the major branches of engineering - our students develop a broad view of the subject much appreciated by employers, but can also choose from a very wide range of specialist options. We have a substantial research portfolio, including much that is directly supported by industry. In the Department there are no barriers between the different branches of engineering, and we are involved in a great deal of … Type: | 20 | 200 |
 | Inkef The Value Within. Inkef is an early stage venture capital firm based in Amsterdam. From the very early stages of a technology or lifescience venture, Inkef supports entrepreneurs building their ideas into successful international businesses. Inkef covers multiple investment stages but focuses mainly on series A investments. For exceptional teams it also considers seed capital to turn a great idea into a company or growth capital to give a running start-up the next push. Inkef is the partner for the long haul. Focus areas: Technology and Healthcare VCfunding, Techstartups, DigitalHealth, Healthcare, Software, therapeutics, Enterprise SaaS, Venture Capital, DeepTech, and LifeScience Type: | 17 | 16 |
 | IQ Capital Supporting Deep Tech entrepreneurs, from Seed Stage to Exit. IQ Capital is a deep-tech early stage VC investing in companies capable of dominating global markets, focused on breakthrough technologies in computer science, energy, life sciences, fintech, space, and advanced engineering. Many of our investments have a strong link to innovation originating in Cambridge and we have made 30+ new investments in the last three years. The IQ Capital team has achieved over 20 exits, to companies including M&A to Apple, Google, Meta, Oracle and several IPOs. We are currently investing up to £10m per company from our fourth fund and … Type: | 35 | 34 |
 | Kindred Capital VC At Kindred we align our ambitions and achievements with our portfolio - in structure and in spirit. Every entrepreneur we invest in becomes a co- owner of the fund. We call it ‘equitable venture’. We invest early and work with our community of founders and advisers to help founders get further, faster from the very beginning. Venture Capital, Technology, and Entrepreneurship Type: | 19 | 21 |
 | Asian Correspondent Asian Correspondent is Asia's leading independent news source, bringing the most important stories in Asia to a regional, English-speaking audience. Combining original features from writers and bloggers across Asia with world class reporting from the news desk in Kuala Lumpur. Asian Correspondent’s coverage offers insight into politics, media and higher education from Bangkok to Beijing and brings readers the stories that rarely make it into English media. Type: | 12 | 1 |
 | Pharmaron Global Life Sciences Services Provider Pharmaron: Global Life Sciences Services Provider Stock Code: 300759.SZ/3759.HK Founded in 2004, Pharmaron is a premier life sciences service provider that offers a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including small molecules, biologics, and CGT products. Pharmaron’s Comprehensive CRO & CDMO Services • Synthetic, Medicinal, and Analytical Chemistry Services • Biology Services (e.g., in vitro screening, structural biology, biomarkers) • DMPK Services (e.g., in vitro ADME, in vivo PK, PKPD, mass balance) • Pharmacology Services (e.g., in vivo … Type: | 4 | 1,971 |
 | Salience Labs Photonics for Data Center AI Salience Labs is a leader in photonic solutions targeting connectivity for AI data center infrastructure. Salience’s innovative developments in photonic switching technology enable high-speed, ultra-low latency networking fabrics that remove bottlenecks for AI workloads. Type: | 2 | 36 |
 | Electroflight Technology and engineering services business. Our core competence is bespoke battery systems for aviation Leverage the disruptive aerospace electrification shift, to enter and establish Electroflight as an industry leading supplier of Energy Storage Systems and surrounding technologies Aviation, Electric propulsion, battery systems, and ESS Type: | 2 | 7 |
 | Harwell Science and Innovation Campus The UK's leading science and innovation campus. Harwell is the UK’s leading science and innovation campus – a unique community of leading scientists, engineers and innovators working together to solve the critical problems facing our planet. Over 7,000 people work in more than 250 organisations at Harwell and these numbers will continue to grow. Our collective goal is to make Harwell the world’s largest and most important location for scientific research, technological development and commercialisation. We are finding solutions for the big challenges of the future including the impact of ageing and growing populations, climate change and sustainability, space exploration … Type: | 38 | 34 |
 | Warner Music Group Warner Music Group (WMG) brings together artists, songwriters, entrepreneurs, and technology that are moving entertainment culture across the globe. Operating in more than 70 countries through a network of affiliates and licensees, WMG’s Recorded Music division includes renowned labels such as 10K Projects, 300 Entertainment, Asylum, Atlantic, Big Beat, EastWest, Elektra, Erato, First Night, Fueled By Ramen, Nonesuch, Parlophone, Reprise, Rhino, Roadrunner, Sire, Spinnin’, Warner Records, Warner Classics, and Warner Music Nashville. WMG’s music publishing arm, Warner Chappell Music, has a catalog of over one million copyrights spanning every musical genre, from the standards of the Great American Songbook to … Type: | 36 | 6,041 |
 | R/GA We design businesses and brands for a more human future. Digital, Advertising, Technology, Marketing, Consulting, Branding, and Design Type: | 49 | 2,843 |
 | Riverlane Making quantum computing more useful far sooner than previously imaginable. Riverlane’s mission is to make quantum computing useful sooner. To achieve this, Riverlane is building the Quantum Error Correction Stack to comprehensively correct the millions of data errors that prevent today’s quantum computers from achieving useful scale. Software, Research, and Quantum Computing Type: | 35 | 130 |
 | Endpoints News The biopharma world is here Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group. Biotechnology, News, Drug Development, and Pharmaceuticals Type: | 27 | 61 |
 | The Guardian Independent journalists since 1821. Follow us here for news you can trust Guardian News & Media (GNM) publishes theguardian.com, one of the world’s leading English-language newspaper websites. It also has a presence in the US and Australia as Guardian US and Guardian Australia. Traffic from outside of the UK now represents around two-thirds of the Guardian’s total digital audience. In the UK, GNM publishes the Guardian newspaper six days a week, first published in 1821, and the world’s oldest Sunday newspaper, The Observer. The Guardian is renowned for its agenda-setting journalism including, most recently the Cambridge Analytica, Paradise and Panama … Type: | 224 | 2,520 |
 | IOP Publishing A society-owned scientific publisher, providing impact, recognition and value for the scientific community We work closely with researchers, librarians, and partners worldwide to produce academic journals, books and conference series. Our aim is to cover the latest and best research in the physical sciences and beyond. As a subsidiary of the Institute of Physics, any surplus made by IOP Publishing goes directly to the Institute to assist their mission to help everyone build their knowledge of physics and to provide professional support for physicists. IOP Publishing supports global schemes such as INASP and EIFL to promote the dissemination of and … Type: | 34 | 610 |
 | OrbiMed OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets. Biotechnology, Healthcare, Financial Services, Fund Management, and Investment Management Type: | 20 | 157 |
 | Amadeus Capital Partners We invest in people who create transformational technologies and sustainable businesses. Amadeus Capital Partners is a global technology investor. Since 1997, the firm has raised over $1bn for investment and used it to back more than 180 companies. With vast experience and a great network, Amadeus’ team of investors and entrepreneurs share a passion for the transformative power of technology. Pioneering businesses we’ve backed include cyber security vendor ForeScout (NASDAQ:FSCT); Graphcore, innovators in intelligent microprocessors; IVF genetic testing company, Igenomix; the first single-chip Bluetooth solution, CSR (acquired by Qualcomm); IndiaMART, the B2B online marketplace (NSE: INDIAMART) and speech recognition company … Type: | 59 | 48 |
 | DLA Piper Global law firm located in more than 40 countries DLA Piper is a global law firm helping our clients achieve their goals wherever they do business. Our pursuit of innovation has transformed our delivery of legal services. With offices in the Americas, Europe, the Middle East, Africa and Asia Pacific, we deliver exceptional outcomes on cross-border projects, critical transactions and high-stakes disputes. Every day we help trailblazing organizations seize business opportunities and successfully manage growth and change at speed. Through our pro bono work and community investment around the world, we help create a more just and sustainable future. Visit … Type: | 141 | 13,377 |
 | Ludwig Cancer Research We are a global community of leading scientists pursuing innovative ways to prevent and control cancer. Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 40 years. Ludwig combines basic science with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested $2.7 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers. To learn more, visit www.ludwigcancerresearch.org. early-phase clinical trials; laboratory research Type: | 6 | 265 |
 |  Oxfordshire Business Awards (OXBA) Recognising and rewarding the success of Oxfordshire businesses For 28 years, the Oxfordshire Business Awards (OXBA) has been recognising, rewarding and promoting the excellence of Oxfordshire-based companies. Organised and supported by many of the county’s leading organisations, the Awards are firmly established as a benchmark for excellence in today’s competitive business environment. Type: | 8 | 2 |
 | The Carlyle Group Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Global Investment Solutions. With $441 billion of assets under management as of December 31, 2024, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,300 people in 29 offices across four continents. Notices & Disclaimers: https://www.carlyle.com/notices-and-disclaimers AlpInvest Private Equity Investment Management, LLC (“APEIM”) is the investment advisor to Carlyle AlpInvest Private Equity Markets (CAPM) … Type: | 66 | 2,528 |
 | Times Higher Education Make smarter, more informed decisions. We are THE, the trusted global data partner for higher education. Drawing on five decades of expertise in the sector, millions of individual data points and with thousands of unique institutions participating in our flagship university rankings, we offer deeper and richer insight into university performance than anyone else. From powerful data-driven insights and strategic consultancy support to agenda-setting events and hiring solutions, our products and services enable everyone in higher education to make smarter, more informed decisions. Universities, Academia, Students, News, Education, World University Rankings, Higher Education Events, Higher Education, Global Impact Rankings, Sustainable … Type: | 45 | 354 |
 | Good News from Finland Discover Finnish startups, SMEs and innovations – and the people behind them. Good News from Finland covers positive and globally interesting news topics related to Finnish startups, SMEs and innovations. We publish news in English and Chinese. The largest share of our international audience can be found in the US, the UK, Sweden, India and Germany. Good News from Finland is a part of Business Finland, a government-funded organisation bringing growth to Finland. (In the U.S. this material is distributed by Business Finland USA Inc. on behalf of Business Finland Ltd.) journalism, media, startups, business, Finland, internationalisation, and innovation Type: | 95 | 5 |
 | Kauffman Fellows The world’s premier venture education program with the largest and most connected network of VC investors in the world. Since 1995, Kauffman Fellows has accelerated the development and success of venture capital investors around the world, supporting Fellows to navigate every aspect of innovation investing, from deal flow to public markets. With 800+ Fellows across 65 countries, Kauffman Fellows is the largest network of VCs and innovation leaders in the world. In the 27 years since inception, Kauffman Fellows have started hundreds of funds, raised and deployed hundreds of billions of dollars in capital, and helped pave the way for … Type: | 54 | 422 |
 | DEEP Ecosystems We empower the most ambitious startup ecosystems to solve the biggest challenges of our times. We believe in entrepreneurs to build ecosystems that solve the biggest challenges of our times. We help to grow and connect ecosystems through our DEEP Startup Ecosystem Accelerator (DEEPSEA), with over 400 alumni since 2018, one of the biggest ecosystem builder communities in the world that gathers twice a year in our DEEP Startup Ecosystem Conference. Both are backed by our data-driven insights on startup ecosystems through our open Startup Heatmap Europe data platform. Startups, Startup Europe, Entrepreneurship, Founders, Founder mobility, Startup Heatmap, DEEP Ecosystems, … Type: | 52 | 24 |
 | Crane Venture Partners First to Believe. Last to Leave. We back ambitious founders building the future of enterprise technology. From inception through every flavour of pre-seed and seed, we provide the right resources at the right time, supporting founders as they scale globally. We’re people helping people dream, deliver, and win. The definition of enterprise software is evolving, and driving our investment strategy. Deep tech, fintech, healthcare, and hardware startups are shaping the next frontier of enterprise solutions—addressing immediate business needs while redefining industries. The globalization of early-stage funding is unlocking new opportunities, making geographic boundaries less relevant. We’ve embraced a borderless investment … Type: | 21 | 22 |
 | GE HealthCare Every day millions of people feel the impact of our intelligent devices, advanced analytics and artificial intelligence. As a leading global medical technology and digital solutions innovator, GE HealthCare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. We embrace a culture of … Type: | 102 | 56,980 |
 | F-Prime We create and invest in healthcare and technology companies that impact lives all over the world. Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds … Type: | 34 | 99 |
 | DCVC Our mission is to invest in founders solving trillion-dollar global problems. DCVC and its principals have backed brilliant people changing global-scale industries for over twenty years, helping create tens of billions of dollars of wealth for founders, employees, and our investors while also making the world a markedly better place. DCVC brings to bear a unique model that unites a team of experienced venture capitalists with more than 35 technology executives and experts (CTOs, CIOs, Chief Scientists, Principal Engineers, Professors at Stanford and Berkeley) with significant tenures at top 100 technology companies and research institutions worldwide. DCVC focuses on seed, … Type: | 71 | 139 |
 | The Netherlands Cancer Institute Today's research for tomorrow's cure The Netherlands Cancer Institute (Het Nederlands Kanker Instituut, NKI) is an exciting and rewarding place to work. It is an internationally recognized center of scientific excellence in many key areas relating to cancer. The NKI also stands out as the only official Comprehensive Cancer Center in The Netherlands. The combination of a research institute and a dedicated cancer clinic (the Antoni van Leeuwenhoek hospital) under one roof facilitates the translation of basal research to clinical applications. It also ensures that our researchers are aware of the most urgent questions our oncologists come across in the … Type: | 7 | 661 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 59 |
 | AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh. AlveoGene has secured an exclusive licence to a proprietary and validated … Type: | 1 | 3 |
 | Oxford Brain Diagnostics Ltd Rethinking brain health. Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases. Type: | 2 | 18 |
 | The Francis Crick Institute We are a biomedical discovery institute breaking down barriers between disciplines. The Crick is a distinctive biomedical research institute. We’re committed to advancing, promoting, and sharing understanding of human health and disease. We do that by attracting talented and ambitious people from all disciplines and backgrounds and giving them the support and freedom they need to succeed. Inside the Crick, you’ll discover scientists working to stretch the very limits of what we know about how life works. Their research holds the key to answering fundamental questions about human health and disease. Our bold and innovative research projects bring together scientists … Type: | 42 | 1,749 |
 | Quantum Motion Scalable Quantum Computing Quantum Motion is developing a revolutionary technology platform; not just a qubit, but a scalable array of qubits fabricated on silicon with a CMOS compatible process. Type: | 14 | 75 |
 | Compiled Get found online. Share all your social media with one link. Get found online. Our user-friendly platform allows you to create a landing page that showcases all your social media links in one place, and more. You can easily match the page's design with your brand's aesthetic. Type: | 79 | 1 |
 | Exact Sciences At Exact Sciences, our purpose is to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment. We're hiring! Our organization offers something for everyone, at all stages of careers and from all backgrounds. Let's take on cancer, together. Precision oncology, Genomic testing, Cancer screening, Genetic testing, and Research and development Type: | 10 | 5,897 |
 | Oxford Capital We are an alternative investment manager, passionate about backing early stage technology companies. Established in 1999, Oxford Capital is an alternative investment manager that is passionate about investing in early stage technology companies where the UK is considered a world leader and has supported over 50 high growth companies. We believe in using the depth and breadth of our experience and expertise to create opportunities where the chances of success are increased for entrepreneurs and their businesses. We partner with founders to deliver meaningful impact in their sector, often taking a seat on the board to help them to shape … Type: | 30 | 24 |
 | Health Innovation Oxford & Thames Valley We work with the NHS, research and industry to identify, develop and spread innovation that will benefit patients, services and economies. Formerly Oxford Academic Health Science Network (Oxford AHSN). nhs, Health, and Innovation Type: | 17 | 50 |
 | NHS The NHS was launched in 1948. It was born out of a long-held ideal that good healthcare should be available to all, regardless of wealth – one of the NHS's core principles. With the exception of some charges, such as prescriptions, optical services and dental services, the NHS in England remains free at the point of use for all UK residents. This currently stands at more than 64.6 million people in the UK and 54.3 million people in England alone. The NHS in England deals with over 1 million patients every 36 hours. It covers everything, including antenatal screening, routine … Type: | 103 | 236,973 |
 | Innovation Forum We drive innovative technology development by connecting innovators, industry, and investors. The Innovation Forum is an international grassroots network that supports scientific entrepreneurs aiming to build ambitious companies at the intersection of science, technology and health. Their IMAGINE IF! initiative is a leading pre-acceleration programme for early-stage science-based ventures providing start-ups with extensive opportunities to take their venture to the next level through structured interactions with key stakeholders, tailored expert mentoring and connections with other founders and companies. Global branches: - UK: Cambridge, Oxford, London, Manchester - US: New York City - Switzerland: Lausanne - Spain: Barcelona - Serbia: Belgrade … Type: | 32 | 49 |
 | UK Biobank Enabling scientific discoveries that improve human health UK Biobank is a large-scale biomedical database and research resource containing genetic, lifestyle and health information from half a million UK participants. UK Biobank’s database, which includes blood samples, heart and brain scans and genetic data of the 500,000 volunteer participants, is globally accessible to approved researchers who are undertaking health-related research that’s in the public interest. UK Biobank recruited 500,000 people aged between 40-69 years in 2006-2010 from across the UK. With their consent, they provided detailed information about their lifestyle, physical measures and had blood, urine and saliva sample collected and … Type: | 19 | 215 |
 | Venionaire DealMatrix TRANSACTIONS MADE EASY DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings. Investments, Startups, Due Diligence, Business Angels, Venture Capital, Corporate Scouting, Valuation, Investor, Venture Investor, Founder, and Matching | 48 | 7 |
 | Caristo Diagnostics Medical Device for Vascular Disease Diagnosis Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagnostic tools to patients worldwide. Our proprietary technology transforms the accuracy of routine cardiac CT scans by extracting new information that is otherwise invisible, greatly enhancing the power to predict cardiovascular risk and refine treatment decisions. Our Website: https://www.caristo.com Follow us on Twitter: https://twitter.com/CaristoHeart Medical Imaging, Artificial Intelligence, Machine Learning, Cardiology, Heart Disease, FAI, Healthcare, Medicine, Clinical Trials, Core Lab, Cloud, and Medical Device Type: | 8 | 49 |
 | PepGen Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics Type: | 1 | 91 |
 | British Pharmacological Society Today's Science, Tomorrow's Medicines The British Pharmacological Society is a charity and global membership community with ~4,000 members from 60+ countries. The BPS's mission is to promote, support and advance the whole spectrum of pharmacology. Founded in 1931, the Society now leads the way in the research and application of pharmacology around the world. It supports pharmacologists via education, career development, networking, events, research, funding, engagement, training, and journals and publishing. 💊🔬🧪🧫💼🎓🎙✨👥🤝 pharmaceutials, pharmacology, clinical pharmacology, education, careers, funding, networking, journals, publishing, engagement, training, and policy Type: | 14 | 216 |
 | 8VC The world's broken, let's fix it 8VC is a venture capital fund based in Austin, Texas. For more information, please visit www.8VC.com Type: | 20 | 171 |
 | The Telegraph The latest news, comment and analysis from The Telegraph The Telegraph’s mission is to provide content that inspires people to have the perspective they want to progress in life. It delivers quality, trusted, award-winning journalism, 24 hours a day, across its digital and print properties as well as through leading digital partners. Founded in 1855, The Telegraph has built a diversified commercial model, with equal strength in advertising, subscriptions and circulation, commerce, and events. In 1994, The Telegraph launched an online offering, the first UK publisher to do so. The launch in 2016 of a digital subscriptions model, with clearly … Type: | 140 | 1,536 |
 | Oxford Instruments plc Oxford Instruments is a leading provider of high technology tools and systems for research and industry. We design and manufacture equipment that can fabricate, analyse and manipulate matter at the atomic and molecular level. Our purpose is to accelerate the breakthroughs that create a brighter future for our world. Benchtop NMR, Etching, Deposition and Growth, Cryogenic Systems, Microanalysis, X-ray Fluorescence, Optical Emission, Coating Thickness, MRI and CT Systems, Low Temperature High Magnetic Field, X-ray Tubes, Plasma Etch and Deposition, Atomic Layer Etch and Deposition, Plasma processing, VCSELs, Semiconductor, Photovoltaics, MEMs, Optoelectronics, Power and Radio Frequency RF, Ion Beam Etch and … Type: | 18 | 1,864 |
 | AGTC Visionary science for life-changing cures. AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments. AGTC's product pipeline includes six named ophthalmology development programs across five targets (X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration and blue cone monochromacy), two non-ophthalmology programs (alpha-1 … Type: | 2 | 77 |
 | Foundation for the National Institutes of Health Forging powerful alliances that support the mission of the NIH and advance breakthrough biomedical discoveries. The mission of the Foundation for the National Institutes of Health (FNIH) is to foster public health through scientific discovery, translational research and the dissemination of research results through specially-configured, high-impact public-private partnerships consistent with the priorities of the National Institutes of Health (NIH). The FNIH is not only involved in large, ambitious initiatives with potentially high impact on the lives of millions of the world’s citizens, but it also supports smaller focused programs in clinical training and ancillary support programs. The FNIH helps to … Type: | 19 | 146 |
 | R Europe (formerly Seedrs) Republic Europe is Europe’s leading private investing platform that empowers the most ambitious investors and companies. Republic Europe (formerly Seedrs) is Europe’s leading private investing platform that enables individuals to invest in startups, growth companies, and, if eligible, leading funds, as well as supports ambitious entrepreneurs in all sectors to raise capital from their communities, angels and institutional investors. Republic Europe is the European operation of Republic - an ecosystem of Web3-optimized financial services built upon compliant investment infrastructure to support micro-transactions on a global scale. To learn more please visit: https://europe.republic.com/ Seedrs Ltd (t/a Republic Europe) is authorised and … Type: | 74 | 122 |
 | Sachs Associates Sachs Associates is a long established international conference company with offices in Switzerland and the UK. Sachs Associates is a long established international conference company with offices in Switzerland and the UK. It runs a limited number of high profile conferences in Europe and the USA which are focused on bio-pharma, medtech, and digital health. These conferences focus on licensing and investment opportunities and all provide presenting opportunities for companies and excellent meeting facilities for all delegates to network. Sachs Associates is focused on the practical benefits accruing from conference participation, the exchange of ideas and information, and the facilitating … Type: | 16 | 19 |
 | Bristol & Bath Science Park A commercial ecosystem designed to feed the roots of Innovation and nurture Success Bristol & Bath Science Park is a world-class environment that provides the space, flexibility & support for science & technology businesses to accelerate their growth and success. It’s a lively business community, designed to actively create opportunities to share knowledge & expertise; inspiring creative thinking & driving innovation. We have everything businesses, academics & entrepreneurs need to confidently push beyond the perceived limits of their own potential, to achieve new & higher levels of success. Set in 59 acres in North Bristol, the Park is conveniently located … Type: | 9 | 2 |
 | Abingworth Life Science Investing Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022. Investing in … Type: | 16 | 43 |
 | Liftstream Executive and Non-Exec Recruitment - Life Sciences / Biotech. - #BoardDirectors, #Csuite, #Leaders - #Diversity #CorpGov Great people elevated to new levels. Type: | 15 | N/A |
![[iito] Life Science](/media/logo/169393.jpeg){kind=logo} | [iito] Life Science Worldwide Mass Spectrometry & Transatlantic Life Science Business News https://t.co/dFBSfg8Zmb, https://t.co/6AvoAqaGQh, https://t.co/znABFjUO2M Type: | 52 | N/A |
 | Mitsubishi Corporation Mitsubishi Corporation (MC) is a global integrated business enterprise that develops and operates businesses together with its global network of around 1,300 group companies. MC operates a wide range of businesses spanning multiple industries and overseen by eight industry-specific business groups: Environmental Energy, Materials Solution, Mineral Resources, Urban Development & Infrastructure, Mobility, Food Industry, Smart Life Creation, and Power Solution. MC’s current activities have expanded far beyond its traditional trading operations to include project development, production and manufacturing operations, working in collaboration with our trusted partners around the globe. With an unwavering commitment to conducting business with integrity and fairness, … Type: | 6 | 6,765 |
 | Upstream Nexus Supporting growth & innovation in science, tech & creative startups & organisations across Hammersmith & Fulham Upstream is a partnership between Hammersmith & Fulham Council and Imperial College London. We have been connecting, supporting and shining a light on the science, tech and creative sectors since 2018. Team Upstream’s work is driven by the belief that local networks that facilitate collaboration and learning, in both planned and serendipitous ways, can accelerate the growth of organisations and places. Our vision is for Hammersmith & Fulham to have an inclusive, thriving ecosystem of ambitious science, tech and creative organisations, with the White … Type: | 33 | 2 |
 | Neu Health Making the latest Parkinson's disease and dementia care accessible for all through innovative digital technologies. Neu Health is making the latest Parkinson's disease and dementia care accessible for all through an innovative, smartphone-based clinical platform and patient programme. We are a spinout from the University of Oxford that builds on 10 years of research and clinical validation. Type: | 3 | 19 |
 | Peptone Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins Type: | 46 | 39 |
 | Qatar Investment Authority Qatar Investment Authority (QIA) is the sovereign wealth fund of the State of Qatar. QIA was established in 2005 to protect and grow Qatar’s financial assets and to diversify its economy. Headquartered in Doha, QIA’s purpose is to generate returns for our future stakeholders. We aim for all our investments to have a positive impact. As a world-class investor, QIA adheres to the strictest financial and commercial discipline. Diversification is key to our approach and our investments span many different markets, asset classes, sectors and geographies. QIA aims to ensure that sustainability principles are embedded across our portfolio. We believe … Type: | 6 | 603 |
 | Cambridge Institute for Sustainability Leadership (CISL) CISL, part of the University of Cambridge, develops leadership and solutions for a sustainable economy. CISL is an impact-led institute within the University of Cambridge that activates leadership globally to transform economies for people, nature and climate. Through its global network and hubs in Cambridge, Cape Town and Brussels, CISL works with leaders and innovators across business, finance and government to accelerate action for a sustainable future. Trusted since 1988 for its rigour and pioneering commitment to learning and collaboration, the Institute creates safe spaces to challenge and support those with the power to act. Sustainability, Education, Business, Innovation, Leadership, … Type: | 136 | 523 |
 | Diesta The first custom built software for premium reconciliation Diesta is developing payment software to modernize the flow of funds in the insurance industry. The result is significant cost savings and sales increases. If you work for an insurance broker or agent, reach out and learn how you can push your company ahead of the competition. | 1 | 12 |
 | +8* | Plus Eight Star +8* is the leading cross-market consultancy on mobile, telecom and Internet in China, Japan and Korea. We work with large companies, SMEs, investment firms and governments worldwide to bring them strategic advice and the best practices from advanced Asian markets. mobile internet technology telecommunications telecom marketing strategy korea japan china asia social networks sns virtual worlds ecommerce coupons web innovation expert advisory investment consultancy consulting +8* plus eight star mobile monday beijing Type: | 42 | 2 |
 | UK Property Forums Independent news and views from Thames Valley, London West & East of England property, design & construction markets. Enabling Property Forums ensuring a balance between editorial and practical 'delivery' management of each event. We have now delivered more than 30 major conferences across the UK and have a reputation for delivering successful 'content' led conferences and events under the banner UK Property Forums. Currently operating in the UK across the regions of the Thames Valley, London and North West markets. This also included an association with the International Festival for Business in 2014 and in 2015 as well. Type: | 17 | 7 |
 | Digital Health Independent business, policy and technology news, research and events focused on developments in health IT Digital Health is an independent news, events, research and networks provider for the digital health community. The Digital Health services were born out of EHI after selling E Health Media and the EHI Live exhibition. We continue to deliver focussed thought and insight in to a complex and changing market Intelligence, News, publishing, CCIO, Digital Health, Health CIO, NHS, Healthcare, Technology, and Health Informatics Type: | 20 | 33 |
 | ArcticStartup The voice of the Northern European startup community. Organisers of #Arctic15 & #NORDEEP ArcticStartup is an independent technology company that reports on digital startups and growth entrepreneurship from the Nordic and Baltic countries. Our goal is to provide exceptional coverage of the news and trends needed to support a developed entrepreneurship community in Northern Europe. ArcticStartup was founded in 2007 and is currently led by Jan Ameri and Vedat Öndas. Our headquarters are located in Helsinki, Finland, however, we cover the startup scenes of Finland, Sweden, Norway, Denmark, Iceland, Estonia, Latvia and Lithuania. Our aim is to encourage entrepreneurship and … Type: | 49 | 15 |
 | Prenetics Prenetics is a leading health sciences company dedicated to advancing consumer and clinical health. Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million joint venture with renowned scientist Prof. Dennis Lo, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses … Type: | 8 | 244 |
 | BusinessCloud News, views and reports from the UK's technology sector. News, views and reports from the UK's technology sector. Technology, Events, Business, Media, Magazine, and Website Type: | 72 | 6 |
 | LocalGlobe We've seeded impactful founders since 1999 at places like Citymapper, Improbable, Lovefilm, Moo, Wise and Zoopla. London's just getting started. Type: | 66 | 54 |
 | CureDuchenne Together, we WILL cure Duchenne! CureDuchenne is the global leader in Duchenne research, patient care and innovation. We are committed to improving the lives of those affected by Duchenne through accelerating research, improving care and empowering the community. We won't stop until everyone has a cure. cureduchenne.org Founded by Paul and Debra Miller in 2003, after their son was diagnosed with the disease, CureDuchenne combines fundraising and venture philanthropy leveraging donor dollars to maximize support for promising research into effective treatments for those suffering from Duchenne. With transparency as a core value, investment proceeds are redeployed to support research and … Type: | 5 | 35 |
![UK Innovation & Science Seed Fund [UKI2S]](/media/logo/165933_sZFF0RK.jpeg){kind=logo} | UK Innovation & Science Seed Fund [UKI2S] We’re UKI2S. One of the largest pre-seed+ funds in the UK with £110m+ AUM. Managed by Future Planet Capital. As a national public seed investment fund we invest, fund and support early-stage businesses and spinouts. We embrace risk. With a 20-year track record of helping tech companies to grow from pre-seed to exit, we put in the work to make your business work. We’ll help you to: → Find the best talent → Establish your board → Fundraise → Advance DE&I → Drive ESG → Deliver impact & more! UKI2S are managed by Future Planet Capital (FPC). FPC helps companies … Type: | 5 | 14 |
 | Chroma Ventures Investing in great ideas and great people. Paddy Burns and Chris van der Kuyl – co-founders of multiple award-winning games developer 4J Studios, best known for developing Minecraft for Microsoft, Sony and Nintendo games consoles established Chroma Ventures as a means of consolidating an investment portfolio focused principally on data-led businesses and those developing and deploying innovative technology. Chroma Ventures channels flexible capital into a range of early-stage and established businesses with high-growth potential. Burns and van der Kuyl have been active supporters – both financially and practically – of a broad range of companies for several years, often in … Type: | 4 | 3 |
 | Oxford Cancer Biomarkers Pioneering Precision Medicine Oxford Cancer Biomarkers translates ground-breaking scientific discovery into predictive biomarker diagnostic products that allow medicines to be personalised for the benefit of the cancer patient. Oxford Cancer Biomarkers is a spin-out of the University of Oxford and has strong links with the Medical Sciences Division in Oxford University. The company was founded by Nick La Thangue, Ph.D., Chair of Cancer Biology at Oxford University and David Kerr, CBE, D.Sc., M.D. FMedSci, Professor of Cancer Medicine at Oxford University. Investors in OCB include Longwall Venture Partners LLP, Esperante BV, Ningbo My-BioMed Biotechnology Co.,Ltd., CancerRop Co. Ltd., and the … | 2 | 8 |
 | OMass Therapeutics OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures and British Patient Capital. Type: | 14 | 82 |
Startup